Covalon Technologies (COV.V) Stock Price

Covalon Technologies Price

TSX·CLOSED
3.96
​
Market closed

Over the last 19 years Covalon Technologies grew revenue by 20.6% annually, reaching 32.82 M CAD. Earnings per share have declined at 9.8% per year over the last 11 years. For Covalon Technologies, the net margin of 6.3% is down versus 120.0% a few years ago. At today's price the dividend yield works out to roughly 3.79%. The payout ratio is around 223% of earnings. The consensus 12-month price target for Covalon Technologies is 2.96 CAD, about 25.3% below where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Covalon Technologies stock price

Access this data via the Eulerpool API

Covalon Technologies business model & stock analysis

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. The company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. The company provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

Frequently asked questions about Covalon Technologies

Analysts currently set an average price target of 2.96 CAD for the Covalon Technologies stock (median: 2.96 CAD), implying -25.3 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Covalon Technologies stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Covalon Technologies to generate revenue of 35.77 M CAD and earnings per share of 0.15 CAD.

Converted at the current exchange rate, the Covalon Technologies share trades at 2.48 EUR (3.96 CAD).

The Covalon Technologies share (COV.V) is listed on 2 stock exchanges, including: Toronto (COV.V).

The expected revenue of Covalon Technologies is 35.77 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Covalon Technologies is 4.70 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Covalon Technologies is currently 25.84. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Covalon Technologies stock.

The price-to-sales ratio (P/S) of Covalon Technologies is currently 3.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Covalon Technologies stock.

The Eulerpool Quality Score for Covalon Technologies is 6/10.

The ISIN of Covalon Technologies is CA22282D3022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Covalon Technologies is COV.V. The ticker symbol is used to trade Covalon Technologies shares on the stock exchange.

Fair ValueTerminal
3.80 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website covalon.com
Country
Currency
CAD
Initial public offering
Sep 3, 2004
ISIN
CA22282D3022
Cusip
22282D302
Market capitalization
109.38 M CADMicro Cap
52-Week Range
PEG
4.16
P/E ratio
P/Ee 2026
23.29
P/Ee 2027
19.80
P/Ee 2028
16.50
P/Ee 2029
14.14
P/Ee 2030
12.00
P/S
P/Se
3.39
EV/EBIT
62.02
P/B Ratio
3.56
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.70 %
Last updated Oct 11, 2026, 1:53 AM

Covalon Technologies Peer Group

Covalon Technologies Ticker

OTC · CVALFTSX · COV.V

Covalon Technologies FIGI

COVCAD:XJ · BBG00KXYW507COV:CN · BBG000HDJVN8COV:CV · BBG000HDJXF3COV:CJ · BBG000HDK0D5COV:TV · BBG000HDL5V3COV:TN · BBG000HDL776COV:TG · BBG000HDL7W8COV:TK · BBG000HDL8T0CVALF:US · BBG000RK7KV9CVALF:UV · BBG000RK7QM6COV:TW · BBG001QLG709COV:DV · BBG003G859Q5